ELAYED tolerance is a phenomenon in which a preconditioning stimulus induces an endogenous form of cellular protection that can persist for several days. In the central nervous system, several different types of preconditioning stimuli have been shown to provide a protective effect against subsequent ischemic cellular injury. These include brief periods of ischemia, 3, [12] [13] [14] [15] [18] [19] [20] 44 spreading depression, 16, 17, 21, 47 hypoxia, 1,6 hyperthermia, 1, 4 repetitive hyperbaric oxygenation, 45, 46 toxins, 41 and cytokines. 28 One drawback of most preconditioning stimuli is that they are also capable of producing injury with only minor changes in their intensity or duration. In the case of ischemia-induced ischemic tolerance, for example, 1 minute of global ischemia is insufficient to elicit tolerance, whereas 2 to 5 minutes of ischemia elicits selective neuronal death. 14, 20 This lack of a suitable safety margin greatly limits the therapeutic utility of ischemic preconditioning in many clinical settings. Recently, we reported that transient hypothermia is an effective preconditioning stimulus for inducing tolerance to ischemic injury. 31 An attractive feature of HPC is that it possesses a broad safety margin. Twenty minutes of HPC at 31.5˚C is capable of inducing ischemic tolerance. This moderate level of hypothermia does not represent a direct risk to neurons because as many as 3 hours of hypothermia at 30˚C has not been shown to damage neurons.
spreading depression, 16, 17, 21, 47 hypoxia, 1, 6 hyperthermia, 1, 4 repetitive hyperbaric oxygenation, 45, 46 toxins, 41 and cytokines. 28 One drawback of most preconditioning stimuli is that they are also capable of producing injury with only minor changes in their intensity or duration. In the case of ischemia-induced ischemic tolerance, for example, 1 minute of global ischemia is insufficient to elicit tolerance, whereas 2 to 5 minutes of ischemia elicits selective neuronal death. 14, 20 This lack of a suitable safety margin greatly limits the therapeutic utility of ischemic preconditioning in many clinical settings. Recently, we reported that transient hypothermia is an effective preconditioning stimulus for inducing tolerance to ischemic injury. 31 An attractive feature of HPC is that it possesses a broad safety margin. Twenty minutes of HPC at 31.5˚C is capable of inducing ischemic tolerance. This moderate level of hypothermia does not represent a direct risk to neurons because as many as 3 hours of hypothermia at 30˚C has not been shown to damage neurons. 5 Consequently, hypothermia can serve as an effective preconditioning stimulus without presenting a direct risk to neural tissue. It is important to note, however, that clinical application of hypothermia is not without possible side effects. Systemic hypothermia, in particular deep hypothermia, has several side effects including increased peripheral vascular resistance, increased cardiac afterload, bradycardia, acidosis, increased blood viscosity, cerebrovascular constriction, and abnormalities in blood coagulation. 23, 36 Fortunately, these side effects are limited and/or manageable at mild-to-moderate levels of hypothermia.
The parameters of HPC that influence the magnitude of delayed tolerance remain to be determined. Clearly, it would be of interest to identify hypothermic conditions under which potential side effects can be minimized, while optimizing the induction of tolerance. In the present study we examined three parameters of HPC to define features of this stimulus that affect tolerance. During the first series of experiments we examined the effects of manipulating the depth of the hypothermic stimulus on tolerance. During the second series we examined the influence of the duration of hypothermic stimulation on tolerance. Finally, during the third series we compared the effects of global (systemic) with focal (cerebral) HPC on tolerance. The results of these studies indicate that the magnitude of ischemic tolerance is dependent on the depth and duration of the hypothermic stimulus, and that focal cerebral hypothermia is an effective preconditioning stimulus for eliciting tolerance.
Materials and Methods

General Procedures
The effects of HPC on subsequent focal ischemic injury were examined using male Sprague-Dawley rats, each of which weighed between 270 and 350 g. All procedures involving animals were approved by the University of Virginia Animal Research Committee. For preconditioning procedures, the rats were initially anesthetized with 4% halothane. The tail artery was cannulated for monitoring blood pressure and HR. Rectal and temporal muscle temperatures were monitored, and the pH, PCO 2 , and PO 2 of blood were assayed during the procedure. The halothane concentration was gradually reduced to 1.5% after induction of anesthesia, and the MABP was maintained at approximately 100 mm Hg. Specific preconditioning parameters are described in later subsections for each experimental series.
Twenty-four hours after preconditioning stimulation, the animals were subjected to focal ischemia by simultaneously occluding the MCA and both CCAs (three-vessel occlusion). For this procedure, the animals were again anesthetized with halothane as described earlier. Orotracheal intubation was performed with care to avoid injury to the upper airways. Breathing was maintained using a mechanical ventilator (Rodent Ventilator model 683; Harvard Apparatus, South Natick, MA) after intubation. The right femoral artery was cannulated for blood pressure monitoring and serial blood gas analysis. Rectal and temporal muscle temperatures were monitored continuously and maintained at 37˚C. Both CCAs were then exposed, with care being taken to preserve the vagus nerve. A loop of silastic tubing was placed around each CCA for subsequent occlusion. Reversible focal ischemia was induced according to the method of Hiramatsu, et al. 9 The animals were placed in a right lateral decubitus position and a 1.5-cm incision was made between the left margin of the orbit and the tragus. The exposed temporal muscle was dissected from the cranium to reveal the infratemporal fossa. After removal of the zygomatic arch, a craniotomy was made slightly anterior to the foramen ovale by using an electric drill with the aid of a surgical microscope. The dura mater was opened carefully and reflected using a 30-gauge needle, thus exposing the MCA bifurcation. A surgical microclip (Sundt AVM micro clip No. 1, Codman and Shurtleff, Raynham, MA) was placed on the MCA at a point just distal to the origin of the lenticulostriate arteries. The silastic loops around both CCAs were closed at the same time. Interruption of blood flow was confirmed visually, and occlusion of the MCA and both CCAs was maintained for 1 hour. The microclip and silastic loops were then removed and reflow was confirmed visually.
The presence and extent of cerebral infarction was evaluated 24 hours after the ischemic event. The animals were given an overdose of pentobarbital and killed by decapitation. Their brains were removed rapidly and 2-mm coronal sections were cut using a McIlwain tissue chopper. Sections of brain were immersed in 2% TTC in phosphate-buffered saline, incubated for 30 minutes at 37˚C, and placed in 10% buffered formalin. After the sections had been stained with TTC, the area of infarction was measured for each section by using image analysis software (Image version 1.57, National Institutes of Health, Bethesda, MD). Total infarct volume was calculated by summing the areas in individual sections and multiplying the attained value by section thickness. In addition, areas of the hemispheres ipsilateral and contralateral to the occluded MCA were measured and total hemispheric volumes were calculated. The actual infarct volume, corrected for swelling, was calculated in the following manner: actual infarct volume = total infarct volume ϫ (contralateral hemisphere volume/ipsilateral hemisphere volume). The values shown in both text and figures are the calculated actual infarct volume.
All data are expressed as means Ϯ SEMs. Differences among groups for physiological parameters and infarct volumes were compared by performing a one-way analysis of variance with an allcomparisons Fisher least significant difference post hoc test. Probability values lower than 0.05 were considered significant.
Experimental Series 1: Depth of Global Hypothermia
During the first series of experiments we manipulated the depth of hypothermia during preconditioning stimulation. The duration of HPC was fixed at 20 minutes, and the depths of hypothermia included 31.5, 28.5, and 25.5˚C (seven animals were used to study each temperature). It should be noted, in this and subsequent experimental series, that the total period of hypothermia is actually longer than the time specified because of the cooling and rewarming periods. The figure associated with each experimental series presents the precise time course of preconditioning stimulation. Global hypothermia was achieved by applying ice packs to the bodies of the animals while they were in a state of anesthesia. Seven animals in a sham-treated control group were anesthetized and maintained at 37˚C for a period matching the duration of preconditioning in the hypothermia-treated groups. Details of the preconditioning, ischemia, and analysis phases of these experiments are presented earlier in this paper.
Experimental Series 2: Duration of Global Hypothermia
In the second series of experiments, we manipulated the duration of the preconditioning stimulus. In these experiments milder levels of hypothermia (33 and 34.5˚C) were used and the duration of preconditioning stimulation was extended. The following hypothermia groups were tested: 1) 33˚C for 20 minutes; 2) 33˚C for 60 minutes; 3) 33˚C for 120 minutes; 4) 34.5˚C for 120 minutes; and 5) 34.5˚C for 180 minutes (seven animals in each group). Groups of shamtreated control animals were subjected to anesthesia at 37˚C for periods matching the hypothermia-treated groups (seven animals in each group). As in the preceding experimental series, global hypothermia was achieved by applying ice packs to the bodies of the animals while they were in a state of anesthesia.
Experimental Series 3: Effects of Focal Brain Cooling
In the two preceding series of experiments we used global (systemic) hypothermia as a preconditioning stimulus. During the third series of experiments we examined the effects of focal brain cooling as a preconditioning stimulus. Ice packs were applied directly to the head of the animal to cool the brain while limiting systemic hypothermia. In pilot experiments, the relationship between brain and systemic temperatures was determined by simultaneously monitoring cerebral cortical, temporal muscle, and rectal temperatures. In these pilot experiments, a craniotomy measuring 2 mm in diameter was made over the MCA supply field and a needle thermistor was placed in the neocortex. During cooling, ice packs were applied to the skin overlying the skull, with care taken not to apply the ice pack directly above the burr hole.
The results of pilot studies demonstrated that when the temporal muscle temperature was lowered to approximately 26˚C and the rectal temperature remained at approximately 37.5˚C, the cortical temperature that was achieved was approximately 31.5˚C. When the temporal muscle temperature was lowered to approximately 25˚C and the rectal temperature was lowered to approximately 34.5˚C, the cortical temperature that was achieved was approximately 28.5˚C. These parameters for rectal and temporal muscle temperatures were used in subsequent experiments in which the effects of focal HPC on ischemic injury were examined. These subsequent experiments did not involve placement of a thermistor in the brain because of the potential for direct injury by the probe. The duration of focal HPC was fixed at 20 minutes with a targeted cortical temperature of 28.5˚C (nine animals) or 31.5˚C (eight animals). These two temperatures were chosen on the basis of their protective effects in the context of global HPC. The cooling-down period for the groups treated with focal hypothermia was 50 minutes and the rewarming period was also 50 minutes. The sham-treated group from Experimental Series 2 that was subjected to 120 minutes of normothermic preconditioning was used as a control group in these studies. This control group was appropriate because it had been subjected to a period of sham treatment that matched the length of preconditioning used in the groups treated with focal hypothermia. Details of the ischemia and analysis aspects of these experiments are presented earlier in this paper.
Results
Experimental Series 1: Depth of Global Hypothermia
The effects of manipulating the depth of hypothermia during preconditioning stimulation were examined in the first series of experiments. The duration of hypothermia was fixed at 20 minutes, and the depth of hypothermia was adjusted to 31.5˚C, 28.5˚C, or 25.5˚C. Physiological parameters monitored before and during preconditioning in these groups are shown in Table 1 . During preconditioning stimulation, the heart rate in the three groups was reduced by 2, 15, and 42% in the 31.5, 28.5, and 25.5˚C groups, respectively. In addition, significant alterations in blood gas levels were observed in the deep (25.5˚C) hypothermia group. The infarct volume of the sham-treated group, which underwent preconditioning at 37˚C, was 150.6 Ϯ 6 mm 3 . Hypothermic preconditioning reduced infarct volume in a manner that was dependent on the depth of the hypothermic stimulus (Fig. 1) . The infarct volumes for the HPC groups were 99.7 Ϯ 11.4 mm 3 for animals in which hypothermia was set at 31.5˚C, 75.3 Ϯ 10.5 mm 3 for animals in which it was set at 28.5˚C, and 42.8 Ϯ 15.9 mm 3 for animals in which it was set at 25.5˚C. Examples of the cerebral infarcts observed in the sham-treated group and 28.5˚C hypothermia group are shown in Fig. 2 .
Experimental Series 2: Duration of Global Hypothermia
The effects of manipulating the duration of hypothermia during preconditioning stimulation were examined in the second series of experiments. The depth of hypothermia was set at 33˚C and the duration of hypothermia was 20, 60, or 120 minutes. Sham-treated groups with matching durations of anesthesia were also evaluated. Physiological parameters monitored before and during preconditioning in these groups are shown in Table 2 . Increasing the duration of HPC resulted in a duration-dependent reduction in cerebral infarction (Fig. 3) . Hypothermic preconditioning at 33˚C reduced infarct volume by 16% in animals subjected to 20 minutes of hypothermia; 22% in those subjected to 60 minutes; and 40% in those subjected to 120 minutes of hypothermia. The reduction in infarct volume achieved statistical significance in the 120-minute hypothermia group.
The effects of preconditioning at a milder level of hypothermia (34.5˚C) were examined in an additional set of experiments. Hypothermic preconditioning at 34.5˚C for periods of 120 and 180 minutes resulted in small reductions (7 and 14%, respectively) in infarct volume that did not achieve statistical significance. The infarct volume of animals subjected to 120 minutes of 34.5˚C hypothermia was 139.3 Ϯ 11.7 mm 
Experimental Series 3: Effects of Focal Brain Cooling
In the previous two series of experiments whole-body cooling was used to achieve brain hypothermia during preconditioning. In this series of experiments we examined focal (head) cooling as a preconditioning stimulus for inducing ischemic tolerance. Brain temperature was lowered to approximately 28.5 or 31.5˚C with associated rectal temperatures of approximately 34.5 and 37˚C, respectively. Cooling to the targeted temperature was performed over 50 minutes, with an additional 50 minutes taken for rewarming. Physiological parameters monitored before and during preconditioning in these groups are shown in Table 3 . The sham-treated group used for this experiment was the same as the 120-minute sham-treated group used . Hypothermic preconditioning via focal cooling reduced cerebral infarction (Fig. 4) . The infarct volumes for the groups preconditioned at 28.5 and 31.5˚C were 78.9 Ϯ 14 and 102.6 Ϯ 9.4 mm 3 , respectively. A comparison of results presented in Figs. 1 and 3 shows that the extent of hypothermia-induced tolerance is comparable in response to focal or systemic cooling at corresponding temperatures.
Discussion
Intraoperative ischemia is an unavoidable complication of many types of invasive surgery. A potentially valuable strategy for limiting cerebral injury during such predictable periods of tissue stress is the prior induction of delayed tolerance. As described earlier in this paper, a variety of preconditioning stimuli are capable of inducing delayed tolerance to ischemic neuronal injury (see review by Nishio, et al.) . 30 Typically, delayed ischemic tolerance develops over a period of several hours, persists for a few days, and is reversed by approximately 1 week after the preconditioning stimulation. In addition, the induction of delayed tolerance can be blocked by protein synthesis inhibitors, indicating that de novo protein synthesis is necessary for the expression of this phenomenon. Recent evidence from our laboratory indicates that another effective stimulus for inducing delayed tolerance is a brief period of hypothermia. 31 Hypothermia-induced tolerance is initiated within 6 hours, peaks at approximately 1 or 2 days, and is reversed by 7 days after the preconditioning stimulation. Hypothermia-induced tolerance is also dependent on de novo protein synthesis and involves direct changes to cells in the brain neuropil. 31 It thus shares a similar temporal course and a dependence on protein synthesis with tolerance induced by other preconditioning stimuli (for example, ischemia).
Preconditioning stimuli capable of eliciting tolerance are, for the most part, rather nonspecific in their actions on target tissues. It would clearly be of benefit to identify the mechanistic underpinnings of delayed tolerance to develop more specific and clinically applicable therapies. Consequently, the cellular and molecular events responsible for Although SEM values are plotted for each group, the values are typically too small to be observed relative to the symbols and lines of the graph. Rectal temperatures were virtually identical to temporal muscle temperatures in these experiments and are not shown. Lower: Bar graph demonstrating mean volumes of infarcts in the groups studied. Twenty-four hours after preconditioning, animals were subjected to focal ischemia, which was followed by a 24-hour survival period. The volume of the cerebral infarct was reduced after HPC, and the amount of reduction correlated with the depth of the hypothermia. Values shown are means Ϯ SEMs. Asterisks denote group values that differed significantly from those of the sham-treated group. ischemic tolerance are matters of intense investigation. A variety of candidate mechanisms has been implicated in this process, including alterations in the following: heat shock proteins, 1, 26, 29 immediate early genes, 11,39 apoptosis-related molecules, 38, 43, 46 superoxide dismutase, 44, 46 adenosine receptors, 7, 8, 32, 33 protein kinase C activity, 33, 42 Akt/ protein kinase B, 48 mitogen-activated protein kinase activity, 40 nitric oxide, 2,27 potassium-adenosine triphosphate channels, 7, 33, 34 and others. Although there is currently no consensus concerning the precise sequence of events responsible for the induction and/or maintenance of delayed ischemic tolerance, the burgeoning literature will likely provide the foundation for future ischemic therapies. Optimally, these therapies will target multiple cellular and molecular mechanisms, and will simultaneously facilitate the actions of endogenous neuroprotective events and inhibit the impact of injurious events. Such goals for the clinical management of ischemic injury are desirable and ultimately achievable, but unfortunately these goals have been slow Hypothermic preconditioning was administered at 33˚C for 20, 60, or 120 minutes. Sham-treated control groups subjected to the same period of anesthesia were examined and compared with animals treated with HPC. The temporal muscle temperature during preconditioning is presented for each group. Rectal temperatures were virtually identical to temporal muscle temperatures in these experiments and are not shown. Lower: Bar graph depicting mean volumes of infarcts in the groups studied. Twenty-four hours after preconditioning, the animals were subjected to focal ischemia followed by a 24-hour survival period. Hypothermic preconditioning reduced the volume of the cerebral infarct, and the infarct was reduced as a function of the duration of the preconditioning stimulus. The reduction in infarct volume achieved statistical significance only in the group that underwent HPC for 120 minutes. An asterisk denotes the group that differed significantly from the sham-treated group. Values shown are means Ϯ SEMs.
to translate into clinical use because of safety and/or efficacy issues.
An alternative, intermediate solution for limiting predictable ischemic damage may be to identify a nonspecific, tolerance-inducing stimulus that can be used in the clinical setting until more specific and targeted therapies become available. Hypothermia-induced tolerance might serve this purpose. It will first be necessary, however, to characterize the key parameters of hypothermic stimuli that influence the induction of delayed tolerance. The present findings contribute to this characterization by demonstrating that the magnitude of ischemic tolerance is dependent on both the depth and duration of hypothermic stimulation. In addition, focal hypothermia can be used to minimize side effects of systemic hypothermia without compromising the magnitude of the tolerance effect.
The potential utility of delayed tolerance as a prophylactic treatment for intraoperative injury will ultimately depend on several factors. One key issue concerns the nature of the preconditioning stimulus used to induce tolerance. Most tolerance-inducing stimuli are noxious and can produce undesirable side effects that directly or indirectly threaten tissue viability. Hypothermia is no exception to this rule; the deleterious side effects of moderate and deep hypothermia are well established. 23, 36 Nevertheless, the major side effects of hypothermia, such as cardiac arrhythmia, decreased cardiac function, and coagulation disorders, occur primarily at systemic temperatures of 30˚C or lower. 25, 35 The findings of the present study demonstrate that mild-to-moderate levels of hypothermia (31.5-33˚C) are effective in producing tolerance to ischemic injury. Previous findings indicate that this range of hypothermia does not represent a direct risk to neurons. 5 Moreover, recent clinical reports demonstrate that prolonged periods (that is, days-weeks) of hypothermia in the same temperature range (32-33˚C) are well tolerated by patients. 10, 24, 37 Taken together, these findings suggest that hypothermia could potentially serve as a tolerance-inducing stimulus in a clinical setting.
Another issue regarding the potential utility of hypo-thermia for inducing tolerance concerns the relative efficacy of global versus focal hypothermia. One possible explanation for the protective effects of global HPC is that reduced cardiac output provides an ischemic challenge to the brain, and that ischemia is actually the key inducing feature of the hypothermic stimulus. This is not an issue at milder levels of hypothermia that induce tolerance, because cardiac output is not significantly affected under these conditions. 25, 35 It is conceivable, however, that reduced cardiac output during deeper hypothermia might create brain ischemia, which could then enhance the magnitude of tolerance. The results of Experimental Series 3 in the present study can be used to argue against this possibility. The results demonstrate that the magnitude of delayed tolerance is similar in response to focal or global cooling when matching levels of brain hypothermia are compared. It is important to note that the animals' HRs were not reduced, but slightly increased, in experiments in which focal hypothermia was used. Moreover, focal brain cooling has previously been shown to increase rather than decrease cerebral blood flow. 22 Thus, the tolerance-inducing effects of hypothermia do not appear to be related to the reduction in HR that accompanies deeper levels of hypothermia.
The finding that focal hypothermia induces tolerance comparable with that of global hypothermia has additional implications for the clinical implementation of HPC. The ability to limit the systemic complications of deeper hypothermia while effecting a hypothermic challenge to the brain could facilitate the safe induction of cerebral tolerance. It should therefore be possible to maximize the magnitude of induced tolerance, while minimizing the potential systemic side effects of hypothermia by using focal preconditioning.
Conclusions
Hypothermic preconditioning elicits a delayed form of tolerance to ischemic injury in the brain. The extent of neuroprotection is dependent on the depth and duration of hypothermic stimulation. In addition, focal brain cooling is as effective as systemic hypothermia for producing tolerance. Hypothermia is a relatively safe preconditioning stimulus compared with most other types of toleranceinducing stimuli and it is already in clinical use for other applications. Taken together, these features suggest that hypothermia could serve as a nontoxic stimulus for inducing delayed tolerance under clinical conditions of anticipated tissue injury.
